CYFIP2: potential pancreatic cancer biomarker and immunotherapeutic target
Abstract Objective It has been shown that the CYFIP2 (Cytoplasmic FMR1-interacting protein 2) gene is apoptosis p53-dependent and is associated with poor prognosis in malignant tumors such as gastric cancer and other and cervical cancer. However, the prognostic potential of CYFIP2 in pancreatic canc...
Saved in:
| Main Authors: | Cong Xiao, Xiaojuan Zhang, Bobo Hou, Ping Wan, Zhenjun Cao, Xuefeng Rao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-12-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-024-01650-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma
by: Peipei Zhang, et al.
Published: (2024-11-01) -
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01) -
Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
by: Nie Zhang, et al.
Published: (2025-01-01) -
TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma
by: Feiming Hu, et al.
Published: (2025-01-01) -
Pan-cancer analysis shows that BCAP31 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types
by: Yangyong Sun, et al.
Published: (2024-12-01)